Ramipril And Loperamide Shoot Up In Early 2021
Pricewatch UK – January 2021
Both ramipril and loperamide saw average UK trade prices that more than doubled in January 2021.
You may also be interested in...
As the UK continued to see a mixture of national lockdown measures and regional restrictions to mitigate the coronavirus pandemic, as well as preparing for the end of its transition period with the EU and the end-of-year holiday period, price changes were unusually muted in December.
Hyloris is on a roll with licensing deals for its Maxigesic IV non-opioid pain treatment, with an extension of its existing agreement with Pharma Bavaria to cover South American territories coming hot on the heels of recent developments in the US and Europe.
Australia’s government has agreed to extend a successful biosimilar education initiative led by the local GBMA industry association.